trending Market Intelligence /marketintelligence/en/news-insights/trending/Y1WxeQ7IuUDjDVeXEnlkww2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Matinas BioPharma raises $12.7M in warrant tender offer


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Matinas BioPharma raises $12.7M in warrant tender offer

Matinas BioPharma Holdings Inc. raised $12.7 million after warrant holders exchanged their holdings for company shares.

A total of 30,966,350 warrants, or 84.31% of all warrants outstanding, were exercised under the company's tender offer.

Proceeds raised will help the company up-list itself to a national securities exchange while advancing its lead anti-infective product candidates MAT2203 and MAT2501 beyond key clinical data readouts during 2017.

SternAegis Ventures acted as the warrant solicitation agent.

Matinas BioPharma is listed on the OTCQB.